Jon Sjostedt

Penumbra FL Vascular

[Penumbra Vascular @PenVascular]

US HCPs: #LightningFlash 2.0 shows low rates of post-procedure transfusion in contrast to recent LBAT data. #TheCompletePEStory

Rx only. Risk info: https://t.co/SILdiRZoH4 Clinical results may vary

[Fakhir Elmasri @ElmasriFakhir]

PE with new FLASH 2.0 for the win!
From Non-rebreather —>97% on room air,
PA pressure drop 44–>19mm
& Flouro time 11 mins. At my age I like PE cases under 40 minutes ! #speedyPE #CAVT

@roblookstein @keithppereira @t_intheleadcoat @vaheesanIR @SIRspecialists

[The PERT Consortium® @PERTConsortium]

Join us on July 11th for a special webinar, "Advancing PE Treatment With Computer-Aided Mechanical Thrombectomy & The Latest Clinical Evidence", supported by @penumbrainc.

Date: Tuesday, July 11, 2023
Time: 7:30pm ET

RSVP: https://t.co/cbUAmFrjyM

[Penumbra Vascular @PenVascular]

US HCPs: 🍲Join us for lunch at #SCVS50 to #FeelThePower of #LightningFlash, learn about our ⚡computer-aided arterial thrombectomy & how #mechanicalocclusion is possible when you #packwithpenumbra with @KateMcGinigleMD, @TomMaldonadoMD, @woostermd, and @JeanBismuth

[Nick Monserez @Nmonz11]

Great case. It’s been very rewarding to hear about the positive impact on patients with the latest FDA approved PE and Venous clot removal therapy.

The recurring feedback has been around the power and speed of the Flash system.

#FeelthePower
#atTheSpeedofFlash
@PenVascular

[woostermd @woostermd]

First #Flash16 @PenVascular case @MUSCVascular. Thankful for the opportunity to provide advanced minimally invasive solutions for our patients. @AdamTanious

[Penumbra Vascular @PenVascular]

US HCPs: 🗣️ Join Drs. Jim Benenati, @farkomd Ripal Gandhi @DrKoethe and @roblookstein as they discuss #LightningFlash ⚡ and Penumbra’s #Embolization platform at #ISET2023 on Tuesday, Jan. 17th from 1-2pm, Poinciana 3 & 4 #FeelThePower #PackWithPenumbra

[Adrian Mercado MD, FACC @AdrianMercadoMD]

ACS thrombus loaded graft attacked with CatRx -->TIMI1 --> Catrx aspiration -->distal nipride ->distal tPa marination

[Shruthi Narayan @knshruthi]

Thank you to all our physicians and partners who stopped by to see us at #VEITH2022. It was SO GREAT to be back in person in NY. Huge kudos to Dr. Frank Veith and team once again.

[Jay Mohan, D.O., FACC, FSCAI, FASE, RPVI @DrJayMohan]

1/ For the fellows and #ACCEarlyCareer!

It’s a coronary thrombus! When to consider thrombectomy? What do you do? Let’s walk through this…#Tweetorial

#Cardiotwitter #Cardiology #STEMI

[Penumbra Vascular @PenVascular]

We invite you to join us for lunch today at #TheVEINS22. Physicians @roblookstein @kush_r_desai @JayMathewsMD and @sternvascular will be presenting on how Penumbra is moving the field forward! #PenumbraInnovation

[Penumbra Vascular @PenVascular]

We hope to see you tomorrow for the Late-Breaking Clinical Trials session at #TheVEINS22

[Penumbra Vascular @PenVascular]

We look forward to seeing you at #VIVA22 and #TheVEINS22.
Stop by booth 202 to learn about our innovative technology! #Lightning #PackwithPenumbra

[Penumbra Vascular @PenVascular]

Our esteemed faculty will discuss the past, present, and future of coronary aspiration this Thursday, at 7pm ET. Interested in learning more? Register here: https://t.co/lszEwv4m3s

[Penumbra Vascular @PenVascular]

Join us next Thursday, October 27that 7PM ET for an interactive session on the future of coronary aspiration! Moderated by Dr. James Benenati with faculty members Drs. @Drroxmehran, @jaymathewsMD, and @DrDarshanDoshi. Register here: https://t.co/lszEwuMKES

[Penumbra Vascular @PenVascular]

Announcing STORM-PE 🫁 First-of-its kind prospective, multicenter, Randomized Controlled Trial evaluating anticoag alone vs anticoag plus Indigo Mechanical Aspiration for the treatment of Intermediate High Risk PE w/ CoPIs @RosovskyRachel @roblookstein #Lightning @PERTConsortium

[Penumbra Vascular @PenVascular]

Please join us virtually to discuss the latest in PE treatment and clinical trials with computer-aided mechanical aspiration #Lightning

[Shruthi Narayan @knshruthi]

Great day at #TCT2022 at Penumbra Symposium with @sahilparikhmd @JayMathewsMD Dr. Metzger and @Drroxmehran. CHEETAH-ACS an international, multi-center, RCT comparing CAT RX + PCI vs. PCI alone for high thrombus burden ACS patients.

[Penumbra Vascular @PenVascular]

Just announced at #TCT2022, Penumbra is taking the next step with CHEETAH-ACS! An international, multi-center randomized controlled trial comparing CAT RX + PCI vs. PCI alone in high thrombus burden ACS patients.

[Penumbra Vascular @PenVascular]

Penumbra’s innovative technology is making an impact on how interventional cardiologists are managing peripheral and coronary thrombus. Find out how by joining us for lunch this afternoon at #TCT2022